Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 175.00
+1.00 (0.57%)
May 7, 2026, 1:19 PM GMT
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 147.3 million as of May 7, 2026. Its market cap has increased by 47.05% in one year.
Market Cap
147.30M
Enterprise Value
138.05M
Revenue
34.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
175.00
Market Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 147.30M, an increase of 121.66%. That is a compound annual growth rate of 11.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 147.30M | 35.52% |
| Dec 31, 2025 | 108.69M | 2.47% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.75B |
| GSK plc | 74.13B |
| Haleon | 29.66B |
| Smith & Nephew | 9.90B |
| Optima Health | 205.04M |
| Tristel | 196.52M |
| Scancell Holdings | 168.64M |
| EKF Diagnostics Holdings | 111.07M |